<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04485897</url>
  </required_header>
  <id_info>
    <org_study_id>895689</org_study_id>
    <nct_id>NCT04485897</nct_id>
  </id_info>
  <brief_title>Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring</brief_title>
  <official_title>Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a&#xD;
      group of diseases that lead to optic nerve damage and corresponding deterioration of the&#xD;
      visual field.&#xD;
&#xD;
      Elevated intraocular pressure remains the most important risk factor. Interestingly,&#xD;
      glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure.&#xD;
&#xD;
      Recent studies suggest pressure peaks, which are missed under the current practice of spot&#xD;
      intraocular measurements during office hours. In order to detect pressure peaks diurnal&#xD;
      measurements are mandatory. Costly in-hospital diurnal measurements are the current standard.&#xD;
&#xD;
      The primary study objective is to verify that self-tonometry at home can provide valuable&#xD;
      information when looking for pressure peaks in patients with glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of an in- hospital diurnal pressure pattern of intraocular pressure to the pattern derived from self-tonometry using icare HOME in an outpatient setting.</measure>
    <time_frame>4 years</time_frame>
    <description>Statistical methods for analysis of continuous method comparison data will be applied. The primary goal is to quantify the extent of agreement between two methods (Intraocular pressure measurement in-hospital and at home) and determine whether they sufficiently agree to be used interchangeably.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>variance of diurnal intraocular pressure</measure>
    <time_frame>4 years</time_frame>
    <description>Quantitative evaluation of day to day variance of diurnal intraocular pressure measurement in an out-hospital setting in patients with open angle glaucoma, normal tension glaucoma and healthy controls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of daily activities</measure>
    <time_frame>4 years</time_frame>
    <description>Influence of daily activities (sports, alcohol and water intake) on intraocular measurements at home (questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of treatment</measure>
    <time_frame>4 years</time_frame>
    <description>Change of treatment due to intraocular pressure peaks during hospitalisation and/or measurements at home</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Intraocular Pressure</condition>
  <arm_group>
    <arm_group_label>icare HOME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>icare HOME device (Icare Oy, Vanda, Finland)</intervention_name>
    <description>icare HOME device versus hospital based measurements</description>
    <arm_group_label>icare HOME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Subjects aged 18 and older&#xD;
&#xD;
          -  Glaucoma patients and healthy controls&#xD;
&#xD;
          -  Best corrected visual acuity &gt;0.1&#xD;
&#xD;
          -  Astigmatism ≤ 3dpt.&#xD;
&#xD;
          -  Good compliance&#xD;
&#xD;
          -  Central corneal thickness (400-650μm)&#xD;
&#xD;
          -  Passed certification procedure (detailed description under: Measurements and&#xD;
             procedures)&#xD;
&#xD;
          -  Therapeutic regimen unchanged throughout the past 30 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of ocular trauma&#xD;
&#xD;
          -  Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual&#xD;
             acuity &lt;0.1&#xD;
&#xD;
          -  Physical or mental disability interfering with self-tonometry (e.g. arthritis,&#xD;
             Parkinson's disease)&#xD;
&#xD;
          -  Dry eye disease&#xD;
&#xD;
          -  Known or suspected non-compliance, drug or alcohol abuse&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g. due to language problems,&#xD;
             psychological disorders, dementia, etc. of the participant&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raphael Fritsche, MD</last_name>
    <phone>0041 205 33 76</phone>
    <email>raphael.fritsche@luks.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cantonal Hospital of Lucerne</name>
      <address>
        <city>Lucerne</city>
        <zip>6004</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 3, 2020</study_first_submitted>
  <study_first_submitted_qc>July 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>self-monitoring</keyword>
  <keyword>intraocular pressure</keyword>
  <keyword>icare HOME</keyword>
  <keyword>rebound tonometry</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

